Balinsua, April Rose Y.
HRN: 27-68-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2025
AMPICILLIN 1GM (VIAL)
09/01/2025
09/08/2025
IV
2g
Q6h
T/C Endometritis
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines